ICD-10 Code D44.0: Neoplasm of uncertain behavior of thyroid gland
What is this code?
ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Neoplasms (C00-D49).
đź“‹Clinical overview
This page concerns a thyroid neoplasm classified as having uncertain behavior. A neoplasm is a growth of tissue; uncertain behavior means its benign or malignant nature cannot be established histologically, by examining the tissue. It is not automatically thyroid cancer or a harmless nodule. The precise pathology wording and clinical findings are needed to understand the diagnosis. This label does not identify a tumor subtype, its hormone activity, its likelihood of recurrence or the treatment required.
When is it used?
- May be used when a clinician documents neoplasm of uncertain behavior of thyroid gland in a patient's medical record.
- May appear in hospital records, claims, referrals, and clinical documentation.
- This code can be used as a clinically usable diagnosis entry in standardized coding workflows.
What it does not mean
- A code alone does not explain severity, treatment plan, or outcome.
- A medical code should not be treated as a substitute for a doctor's diagnosis or advice.
🩺Clinical context
- Records documenting a thyroid neoplasm whose behavior is classified as uncertain. The official category is distinct from unspecified behavior, a benign thyroid growth and a confirmed malignant thyroid tumor; do not silently exchange those diagnoses.
- Some thyroid tumors have tissue features that are difficult to place confidently into benign or malignant groups. Uncertain malignant potential is a pathology concept, not simply a statement that an appointment, ultrasound or laboratory result is still pending.
- An indeterminate fine-needle sample and a tissue diagnosis of uncertain behavior are not automatically the same finding. The actual report and clinical interpretation matter; D44.0 does not assign a Bethesda or Thy cytology category, NIFTP or a particular follicular tumor subtype.
- Review the exact cytology, surgical pathology and operative reports with the thyroid team. They can explain what tissue was examined, which features remain uncertain and whether specialist pathology review would help; the code alone does not describe invasion, margins or a molecular result.
- Neck examination and ultrasound provide structural information, while tests such as TSH assess thyroid function. Normal hormone results do not establish benign behavior, and an abnormal hormone result does not by itself prove malignancy.
- Further sampling, molecular tests or imaging are chosen only where they answer a specific remaining question. Some tissue distinctions require examination of a resected specimen rather than a needle sample. The title does not require repeating a biopsy or undergoing a new operation in every case.
- Agree a plan based on the precise diagnosis, what treatment has already occurred, any remaining thyroid findings and the person's circumstances. Ask the endocrinologist or surgeon to distinguish what is known from what remains uncertain.
- Further surgery or radioactive iodine is not an automatic consequence of D44.0. Current guidance does not routinely recommend these additional treatments for certain pathologically defined very-low-potential tumors, but this broad code alone does not establish that an individual has one of those tumors.
- Follow-up should be tailored to the report and clinical situation. Ask which examinations, blood tests or ultrasound checks are useful and when to report a change. Do not borrow a fixed cancer-surveillance schedule or assume that uncertain behavior means no review is needed.
- If thyroid hormone treatment is already prescribed, follow the agreed plan and discuss changes with the clinician. This code does not establish an underactive or overactive thyroid or require thyroid-suppressing treatment, iodine supplements or a cancer-drug regimen.
🔍Key distinctions
- A growing neck lump, persistent voice change or difficulty swallowing needs clinical review. Difficulty breathing or noisy breathing needs emergency medical help rather than waiting for a routine pathology discussion; a pressure symptom does not itself prove cancer.
- Uncertain behavior does not mean a particular percentage chance of cancer, inevitable progression, spread or a precancer diagnosis in every case. Neither the risk estimate from an indeterminate needle-sample study nor another person's outcome can be assigned from this code.
- WHO classifications distinguish certain low-risk thyroid neoplasms from benign tumors and carcinomas. These are specific entities with their own criteria, not a reason to label every D44.0 page NIFTP or to apply one entity's treatment or follow-up to all others.
- This is a thyroid diagnosis, not a parathyroid neoplasm or proof of an inherited endocrine syndrome. Preserve the original uncertain-behavior classification while clarifying its meaning; do not rewrite it as benign or malignant without the relevant clinical evidence.
Code hierarchy
Where you may see this code
You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records.
Related specialists
Related codes
Sibling codes
Coverage-related procedures and services
Mapped diagnoses and classifications
Coding guidelines
Compatibility
Common synonyms
Frequently asked questions
📚References
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.